Min Ding Selected Research

Facial Paralysis (Facial Palsy)

10/2015	[Intractable facial paralysis treated with different acupuncture and acupoint embedding therapies: a randomized controlled trial].
9/2010	[Facial nerve function index evaluation on deviation of the mouth in intractable facial palsy treated with sticking needle and traction method on three points of the mouth].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Ding Research Topics

Disease

48	Neoplasms (Cancer) 01/2024 - 08/2002
11	Carcinogenesis 10/2018 - 02/2002
9	Intrahepatic Cholestasis of Pregnancy 01/2022 - 12/2007
8	Inflammation (Inflammations) 02/2023 - 07/2008
7	Infections 01/2024 - 03/2014
7	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2012
6	Sepsis (Septicemia) 03/2024 - 07/2009
5	Liver Neoplasms (Liver Cancer) 10/2020 - 05/2015
4	Acute Kidney Injury (Acute Renal Failure) 03/2024 - 12/2011
4	Obesity 01/2024 - 10/2007
4	Critical Illness (Critically Ill) 01/2024 - 06/2016
4	Diabetes Mellitus 01/2023 - 07/2007
4	Hypertension (High Blood Pressure) 01/2023 - 01/2012
4	Fibrosis (Cirrhosis) 01/2023 - 03/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2012
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2006
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2007
4	Pneumonia (Pneumonitis) 08/2020 - 01/2002
4	Septic Shock (Toxic Shock Syndrome) 09/2018 - 07/2009
4	Lung Neoplasms (Lung Cancer) 01/2014 - 03/2005
3	Diarrhea 12/2023 - 04/2021
3	COVID-19 11/2023 - 08/2020
3	Hemorrhage 01/2023 - 10/2005
3	Breast Neoplasms (Breast Cancer) 09/2022 - 10/2010
3	Pheochromocytoma 05/2022 - 03/2018
3	Paraganglioma (Paragangliomas) 05/2022 - 03/2018
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 08/2021 - 01/2020
3	Hypoxia (Hypoxemia) 08/2020 - 05/2002
3	Atherosclerosis 06/2018 - 01/2017
3	Ischemia 01/2018 - 07/2007
3	Male Infertility (Male Sterility) 06/2015 - 01/2015
3	Multiple Organ Failure (MODS) 12/2011 - 07/2009
3	Silicosis 08/2006 - 02/2002
2	Pancreatitis 04/2024 - 01/2011
2	Insulin Resistance 10/2023 - 01/2017
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2023 - 12/2019
2	Tuberculosis (Tuberculoses) 01/2023 - 02/2002
2	Ulcer 01/2023 - 11/2022
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 11/2017
2	Chronic Disease (Chronic Diseases) 01/2022 - 01/2022
2	Thyroid Nodule (Nodule, Thyroid) 01/2022 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2018
2	Chronic Renal Insufficiency 01/2021 - 05/2013
2	Digestive System Diseases 10/2018 - 11/2016
2	Peripheral Arterial Disease 06/2018 - 09/2015
2	Myocardial Infarction 01/2018 - 11/2017
2	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2017 - 08/2016

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2007
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2008
11	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 08/2007
10	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 02/2022 - 05/2002
7	MicroRNAs (MicroRNA)IBA 01/2024 - 05/2014
7	NF-kappa B (NF-kB)IBA 01/2017 - 02/2002
6	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2016
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 05/2002
5	RNA (Ribonucleic Acid)IBA 04/2024 - 11/2010
5	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2022
5	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 02/2002
5	Therapeutic UsesIBA 01/2021 - 05/2006
5	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 01/2012
5	AntioxidantsIBA 05/2007 - 01/2004
5	CarcinogensIBA 06/2006 - 02/2002
4	Long Noncoding RNAIBA 03/2024 - 01/2017
4	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2017
3	Insulin (Novolin)FDA Link 10/2023 - 10/2007
3	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 07/2007
3	pinaveriumIBA 08/2021 - 01/2020
3	Lactic Acid (Lactate)FDA LinkGeneric 12/2019 - 07/2009
3	AutoantibodiesIBA 01/2019 - 02/2008
3	CholesterolIBA 06/2018 - 01/2017
3	indoleIBA 12/2017 - 04/2012
3	Oxygen (Dioxygen)IBA 09/2014 - 01/2011
3	C-Reactive ProteinIBA 12/2011 - 07/2007
3	Silicon Dioxide (Silica)FDA LinkGeneric 08/2006 - 02/2002
2	IndolesIBA 10/2023 - 12/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 09/2022
2	3-methoxytyramine (methoxytyramine)IBA 05/2022 - 11/2020
2	LipidsIBA 01/2022 - 01/2017
2	Circular RNAIBA 01/2022 - 09/2019
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2021 - 01/2020
2	AlbuminsIBA 01/2021 - 01/2020
2	Liraglutide FDA Link 01/2019 - 01/2017
2	AntibodiesIBA 01/2018 - 07/2016
2	Small Interfering RNA (siRNA)IBA 01/2017 - 10/2007

Therapy/Procedure

22	Therapeutics 11/2023 - 05/2007
5	Artificial Respiration (Mechanical Ventilation) 12/2022 - 06/2016
5	Hemofiltration 09/2018 - 07/2009
4	Radiofrequency Ablation 10/2023 - 10/2018
4	Surgical Amputation (Amputations) 01/2023 - 09/2015
3	Drug Therapy (Chemotherapy) 01/2024 - 09/2022
3	Resuscitation 09/2014 - 07/2009
3	Aftercare (After-Treatment) 09/2014 - 03/2006
2	Radiotherapy 09/2022 - 01/2016
2	Transplantation 01/2022 - 01/2021
2	Immunotherapy 01/2022 - 01/2016
2	Moxibustion 01/2022 - 05/2007
2	Length of Stay 01/2021 - 01/2019
2	Acupuncture Therapy 01/2021 - 06/2013